Skip to content

Is Hair Loss a Side Effect of Xiidra? Uncovering the Facts

4 min read

In the United States, over 30 million people suffer from dry eye disease [1.5.3]. For many prescribed Xiidra, a pressing question arises: is hair loss a side effect of Xiidra? This article explores the official data and underlying connections.

Quick Summary

This article examines the evidence regarding the link between Xiidra and hair loss, detailing the medication's common side effects, mechanism of action, and what clinical trial data reveals about its safety profile.

Key Points

  • No Direct Link: Hair loss is not a side effect of Xiidra according to clinical trials and FDA prescribing information [1.2.2, 1.4.3].

  • Common Side Effects: The most common side effects of Xiidra are eye irritation, an unusual taste (dysgeusia), and temporary blurred vision [1.4.3].

  • Autoimmune Connection: Both dry eye disease and hair loss (alopecia) can be symptoms of underlying autoimmune conditions like Sjögren's syndrome or lupus [1.6.1].

  • Mechanism of Action: Xiidra is a non-steroid LFA-1 antagonist that reduces inflammation on the eye's surface [1.2.4, 1.5.1].

  • Localized Effect: Xiidra is an eye drop with low systemic absorption, so its effects are primarily limited to the eyes and immediate surrounding areas [1.2.4].

  • Consult a Doctor: If you experience hair loss while using Xiidra, it's important to speak with a doctor to determine the actual cause [1.2.1, 1.2.4].

  • Indirect Association: Studies show a high prevalence of dry eye disease in patients with alopecia areata, suggesting a shared inflammatory pathway [1.6.4, 1.6.5].

In This Article

What is Xiidra and How Does It Work?

Xiidra, with the active ingredient lifitegrast, is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) [1.4.3]. It is not a steroid; instead, it belongs to a class of drugs known as lymphocyte function-associated antigen-1 (LFA-1) antagonists [1.2.4, 1.5.6]. The exact mechanism of action in DED is not fully known, but it's understood that inflammation on the ocular surface plays a key role in the condition [1.4.3, 1.5.1].

Lifitegrast works by binding to LFA-1, a protein found on the surface of immune cells called T-cells, and blocking it from interacting with another protein called intercellular adhesion molecule-1 (ICAM-1) [1.5.1]. ICAM-1 can be overexpressed in the eye tissues of people with DED, and the LFA-1/ICAM-1 interaction contributes to T-cell activation and migration, which perpetuates the inflammatory cycle [1.5.1]. By blocking this interaction, Xiidra is thought to inhibit the release of inflammatory cytokines, thereby reducing inflammation and relieving the symptoms of dry eye [1.4.3, 1.5.2].

Official Stance: Is Hair Loss a Side Effect of Xiidra?

According to official prescribing information and data from clinical trials, hair loss is not a reported side effect of Xiidra [1.2.2, 1.2.3, 1.4.7]. Studies involving over 1,400 patients did not list hair loss (alopecia) as an adverse reaction [1.4.3]. Because Xiidra is an ophthalmic solution with very low systemic absorption, its side effects are primarily localized to the eyes and surrounding areas [1.2.4, 1.3.1]. The most common adverse reactions occur shortly after the drops are administered and are generally temporary [1.3.3].

If you experience hair loss while using Xiidra, it is important to consult your doctor [1.2.1]. The hair loss is likely due to another cause, and a medical professional can help determine the underlying reason [1.2.4].

The Connection Between Dry Eye, Hair Loss, and Autoimmune Conditions

While Xiidra itself does not cause hair loss, there can be an indirect link between the condition it treats (dry eye disease) and hair loss [1.2.1]. Both dry eyes and certain types of hair loss, like alopecia areata, can be manifestations of underlying systemic autoimmune diseases [1.6.1, 1.6.6].

  • Autoimmune Connection: Conditions such as Sjögren's syndrome, lupus, and alopecia areata involve the immune system mistakenly attacking the body's own tissues [1.6.1, 1.6.3]. In Sjögren's, the immune system attacks moisture-producing glands, leading to dry eyes and dry mouth [1.2.6]. In alopecia areata, T-cells attack hair follicles, causing hair loss [1.6.3]. The T-cell mediated inflammation common to both alopecia areata and DED suggests a potential shared pathogenic mechanism [1.6.4, 1.6.5].
  • Research Findings: One study involving 32 patients with alopecia areata found that 84% also had a diagnosis of dry eye disease, a significantly higher prevalence than in the control group [1.6.4, 1.6.5]. This suggests that individuals with autoimmune-related hair loss are more likely to experience DED. Therefore, a person might notice both symptoms concurrently, not because one causes the other, but because both stem from a common systemic issue [1.2.1].

Common Side Effects of Xiidra

The most common side effects reported in 5% to 25% of patients during clinical trials are localized and often temporary [1.4.3, 1.3.6]. They include:

  • Eye Irritation: This is the most frequent side effect, often described as stinging or burning upon instillation of the drops [1.3.1, 1.4.3].
  • Dysgeusia (Unusual Taste Sensation): Many users report a metallic or unusual taste in their mouth shortly after administration. This occurs because the tear ducts drain into the nasal cavity and then the back of the throat [1.3.1, 1.3.3].
  • Reduced Visual Acuity: Some patients experience temporary blurred or unclear vision immediately following application [1.3.1, 1.4.3].

Other less common side effects (reported in 1-5% of patients) include headache, sinusitis, watery eyes, eye discharge, and conjunctival hyperemia (redness) [1.4.3]. Severe allergic reactions are rare but have been reported post-marketing and require immediate medical attention [1.3.6].

Comparison Table: Xiidra vs. Restasis

Restasis (cyclosporine) is another common prescription medication for dry eye disease. While both treat DED, they have different mechanisms and side effect profiles [1.7.3, 1.7.6].

Feature Xiidra (lifitegrast) Restasis (cyclosporine)
Primary Mechanism LFA-1 antagonist; blocks T-cell interaction [1.5.6] Calcineurin inhibitor; reduces inflammation [1.3.2]
Most Common Side Effect Eye irritation, unusual taste (dysgeusia) [1.4.3] Ocular burning sensation [1.7.4, 1.7.5]
Other Common Effects Blurred vision, eye discharge, headache [1.7.2] Eye redness, watery eyes, eye pain [1.7.5, 1.7.6]
Unique Side Effect Unusual taste sensation (dysgeusia) is notable [1.7.6] Ocular burning is the most prominent effect [1.7.4]
Onset of Action May provide relief in as few as 2 weeks for some [1.3.3] May take 3 months or longer for full effect [1.7.1]

What to Do If You Experience Side Effects

If you experience any side effects while using Xiidra, especially if they are severe or persistent, it's important to talk to your doctor [1.2.2]. For common, mild side effects like the unusual taste, chewing sugar-free gum or drinking plenty of water can help [1.3.5]. For application-site irritation, ensure you are not touching the dropper tip to your eye or any other surface to avoid contamination [1.4.1]. If you experience symptoms of a severe allergic reaction, such as difficulty breathing or a swollen tongue, seek medical care immediately [1.3.3, 1.4.2].

Link: Read the full FDA Prescribing Information for Xiidra

Conclusion

Based on extensive clinical trial data and official prescribing information, hair loss is not a recognized side effect of Xiidra eye drops [1.2.1, 1.2.2]. The medication's action is localized to the eye, and its most common side effects are temporary irritation, taste changes, and blurred vision [1.4.3]. However, a notable association exists between the underlying causes of dry eye disease and certain types of hair loss, particularly in the context of autoimmune disorders like alopecia areata and Sjögren's syndrome [1.6.1, 1.6.4]. Patients experiencing both dry eyes and hair loss should consult their healthcare provider to investigate for a potential underlying systemic condition rather than attributing the hair loss to their eye medication [1.2.1].

Frequently Asked Questions

No, hair loss was not reported as a side effect in the clinical studies of Xiidra [1.2.2, 1.2.3].

The most common side effects, occurring in 5-25% of patients, are eye irritation upon application, an unusual taste sensation (dysgeusia), and temporary blurred vision or reduced visual acuity [1.4.3, 1.3.6].

Yes, an indirect connection can exist. Both dry eye disease and hair loss (alopecia) can be symptoms of an underlying autoimmune condition, such as Sjögren's syndrome or lupus [1.6.1, 1.6.3].

This side effect, known as dysgeusia, occurs because your tear ducts connect your eyes to your nasal cavity, allowing some of the medication to drain down the back of your throat [1.3.1].

No, Xiidra is not a steroid. It is a non-steroid medication called a lymphocyte function-associated antigen-1 (LFA-1) antagonist [1.2.4, 1.3.3].

You should talk to your doctor. Since hair loss is not a known side effect of the drug, your doctor can help investigate other potential causes for the hair loss [1.2.1].

Xiidra's most unique side effect is an unusual taste, while Restasis is most known for causing a burning sensation in the eyes. Both can cause eye irritation and blurred vision [1.7.4, 1.7.5, 1.7.6].

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.